Delivery Order SPE2DB22D3501-SPE2DB25FUB29
Award Date
1/7/25
Potential Completion Date
1/8/25
Potential Value
$9.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $17,781.12 fixed-price contract is for the supply of ONTRUZANT 420 MG VIALS, a specialty medication. The contract has an ultimate completion date of October 30, 2024 and is not designated as a set-aside contract.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ONTRUZANT 150 MG VIALS. The contract has a firm fixed price of $1,255.30 and a completion date of November 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a wide range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ONTRUZANT 420 MG VIALS. The contract has a ceiling value of $8,115.64 and runs through January 9, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of the pharmaceutical product ONTRUZANT 150 MG VIALS. The contract has a ceiling value of $15,925.81 and a completion date of May 10, 2024.
AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DOD) and Department of Veterans Affairs...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,445.43 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of ONTRUZANT 420 MG VIALS, with a completion date of March 8, 2024. This delivery order is issued under an indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ONTRUZANT 420 MG VIALS. The contract has a potential value of $27,236.77 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an Indefinite Delivery Contract (IDC) awarded by DLA to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $42,275.51 firm fixed price delivery order is for the pharmaceutical product "ONTRUZANT 150 MG VIALS" and has a completion date of May 14, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The $10,566.04 Firm Fixed Price Delivery Order is for the provision of ONTRUZANT 420 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2024.
Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award is for the delivery of ONTRUZANT 150 MG VIALS to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, with a total ceiling value of $11,437.80. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation.
Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $88,316.80, is for the delivery of a variety of medical products and supplies to support TRICARE, the military healthcare program. The contract is a Firm Fixed Price type with an ultimate completion date of March 25, 2016. Amerisourcebergen holds a larger $999,999,999...